Lidocaine may exert its anti-cancer effects indirectly by inhibiting PI3K/Akt, which, in turn, affects Hippo signaling, while linolenic acid has been shown to maintain YAP levels in the cytoplasm and directly inhibit cancer cell growth through the Hippo pathway. This evidence concerns the gene YAP1 and cancer.